Literature DB >> 16681805

In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans.

H C Sigle1, M Schäfer-Korting, H C Korting, B Hube, M Niewerth.   

Abstract

Rilopirox and piroctone belong to the class of hydroxypyridone antimycotics. This class is not related to other antimycotics. In contrast to azole antimycotics and polyene antimycotics the mode of action of hydroxypyridone antimycotics is not fully understood. Inhibition of cellular uptake of essential compounds as well as loss of other compounds seems to be only a secondary effect of a primary not known action of these drugs. The antifungal effect in vitro depends on the medium used. The hyphal induction of Candida albicans is inhibited by hydroxypyridone antimycotics, but this effect is compensated by iron ions. A damage of the cell membrane and a direct influence on adenosine triphosphate synthesis, respectively, do not seem to be part of the mode of action. But there are clear hints that reactive oxygen species (ROS) and available metabolic activity are important parts of the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681805     DOI: 10.1111/j.1439-0507.2006.01228.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

Review 1.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

Review 2.  Treatment of superficial mycoses: review. Part II.

Authors:  Maria Fernanda Reis Gavazzoni Dias; Fred Bernardes-Filho; Maria Victória Pinto Quaresma-Santos; Adriana Gutstein da Fonseca Amorim; Regina Casz Schechtman; David Rubem Azulay
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

3.  Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis.

Authors:  Fabíola Maria Marques do Couto; Silene Carneiro do Nascimento; Silvio Francisco Pereira Júnior; Vanessa Karina Alves da Silva; André Ferraz Goiana Leal; Rejane Pereira Neves
Journal:  Springerplus       Date:  2016-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.